Hyperthermic isolated limb perfusion (ILP) effectively treats locally recur
rent metastatic disease in malignant melanoma of the extremities. The goal
of ILP is to decrease the rate of further recurrent disease and eradicate t
umor load to achieve wound hygiene and preservation of limb function. This
article reviews the development over the last 45 years of ILP in the treatm
ent of malignant melanoma, describes the surgical technique of ILP, and rev
iews the results of clinical trials with various chemotherapeutic agents,It
discusses the recent addition of tumor necrosis factor alpha to the list o
f drugs currently being explored in hyperthermic ILP, in the ongoing attemp
t to improve the treatment for recurrent malignant melanoma of the extremit
ies.